investiment.io
Forte Biosciences, Inc.
$5.93
0.19 (3.22%)
Forte Biosciences, Inc.
$5.93
0.19 (3.22%)
FBRX Price Chart
| Basic | |
|---|---|
| Market Cap | $6.72M |
| Price | $5.93 |
| 52 Week Range | 4.11-21.25 |
| Beta | 1.43 |
| Margins | |
| Gross Profit Margin | -316.67% |
| Operating Profit Margin | -593866.67% |
| Net Profit Margin | -569916.67% |
| Valuation (TTM) | |
| P/E Ratio | -0.32 |
| Price to Sales Ratio | 1443.68 |
| Price to Book Ratio | 1.17 |
| PEG Ratio | -0.01 |
Industry
Biotechnology
Sector
Healthcare
Full-Time Employees
11
Website
IPO Date
2017-04-13T00:00:00.000Z
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Phone
310 618 6994
Address
3060 Pegasus Park Drive, Dallas, TX, 75247, US
CIK
0001419041